Impact of the RNF213 p.R4810K Variant on Endovascular Therapy for Large‐Vessel Occlusion Stroke

Impact of the RNF213 p.R4810K Variant on Endovascular Therapy for Large‐Vessel Occlusion Stroke

Background We investigated the impact of the ring finger protein 213 p.R4810K variant, a founder variant for moyamoya disease in East Asians, on endovascular therapy outcomes in patients with acute anterior‐circulation large‐vessel occlusion stroke in comparison with noncarriers. Methods Of the cons...

Full description

Bibliographic Details
Main Authors: Takeshi Yoshimoto, Kanta Tanaka, Junpei Koge, Satoshi Saito, Hiroshi Yamagami, Yuriko Nakaoku, Soshiro Ogata, Kunihiro Nishimura, Eriko Yamaguchi, Tetsuya Chiba, Daisuke Kawakami, Masayuki Shiozawa, Naruhiko Kamogawa, Tsuyoshi Ohta, Tetsu Satow, Manabu Inoue, Yorito Hattori, Kazuo Washida, Hiroharu Kataoka, Jong‐Won Chung, Oh Young Bang, Kazunori Toyoda, Masatoshi Koga, Hirofumi Maruyama, Masafumi Ihara
Format: Article
Language:English
Published: Wiley 2022-11-01
Series:Stroke: Vascular and Interventional Neurology
Subjects:
endovascular therapy
RNF213 p.R4810K
stroke
Online Access:https://www.ahajournals.org/doi/10.1161/SVIN.122.000396

Internet

https://www.ahajournals.org/doi/10.1161/SVIN.122.000396

Similar Items